ID   SNU_MM1393_BM
AC   CVCL_IW63
SY   SNU MM1393 BM; Seoul National University-Multiple Myeloma 1393-Bone Marrow
DR   ABM; T8214
DR   Wikidata; Q54955300
RX   PubMed=25343143;
CC   Population: Korean.
CC   Characteristics: Established from a bone marrow tumor in a NRG/SCID mice injected with the patient cancer cells (PubMed=25343143).
CC   Characteristics: Produces IgA kappa (PubMed=25343143).
CC   Characteristics: IL6 dependent (PubMed=25343143).
CC   Doubling time: ~48 hours (PubMed=25343143).
CC   Karyotypic information: Near tetraploid karyotype (PubMed=25343143).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IW64 ! SNU_MM1393_SC
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 10
//
RX   PubMed=25343143; DOI=10.1155/2014/510408; PMCID=PMC4197890;
RA   Koh, Youngil
RA   Jung, Woo-June
RA   Ahn, Kwang-Sung
RA   Yoon, Sung-Soo
RT   "Establishment of cell lines from both myeloma bone marrow and
RT   plasmacytoma: SNU_MM1393_BM and SNU_MM1393_SC from a single patient.";
RL   BioMed Res. Int. 2014:510408.1-510408.8(2014).
//